Contact Us
Portal Login

Comparison of the prevalence of advanced fibrosis (AF) using two combinations: Liver stiffness measurement (LSM or VCTE Fibroscan) along with LIVERSTAT (LST) or FIB-4 in a prospective chronic liver diseases (CLD) cohort

Comparison of the prevalence of advanced fibrosis (AF) using two combinations: Liver stiffness measurement (LSM or VCTE Fibroscan) along with LIVERSTAT (LST) or FIB-4 in a prospective chronic liver diseases (CLD) cohort

AI-based blood tests LIVERSTAT for advanced fibrosis (AF) in patients with T2D can streamline the diagnostic process.

Aim of this study is to retrospectively evaluate two combinations, LIVERSTAT & Liver Stiffness measurement (LSM) and FIB-4 & LSM, in identifying presumed advanced fibrosis among pts with T2D and MASLD. 

Scroll to Top

Contact Us

We are always ready to help you with your liver problems

For clinical and medical enquiries, contact us at: medicalaffairs@fibronostics.com